NCT00816062

Brief Summary

The purpose of this study is to examine, through the endpoints established in this protocol, the long-term safety and effectiveness of the Talent Abdominal Stent Graft System, in a post-approval environment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

18 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

December 29, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 31, 2008

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

January 23, 2018

Completed
Last Updated

October 29, 2021

Status Verified

October 1, 2021

Enrollment Period

6.6 years

First QC Date

December 29, 2008

Results QC Date

August 1, 2016

Last Update Submit

October 27, 2021

Conditions

Keywords

Aortic AneurysmAneurysmAbdominal Aortic AneurysmTalentMedtronic

Outcome Measures

Primary Outcomes (1)

  • Freedom From Aneurysm-related Mortality (ARM)

    ARM is defined as death from rupture of the abdominal aortic aneurysm or from any procedure intended to treat the Abdominal Aortic Aneurysm (AAA). If a death occurred within 30 days of any procedure intended to treat the AAA, then it is presumed to be aneurysm related unless there is evidence to the contrary. Deaths occurring after 30 days of any procedure intended to treat the AAA that are procedure-related should also be aneurysm related. All deaths were adjudicated by a Clinical Events Committee (CEC) to determine aneurysm, device and/or procedure relatedness.

    5 year Kaplan Meier (KM)

Study Arms (1)

Treatment

EXPERIMENTAL

Patients diagnosed with an abdominal aortic or aorto-iliac aneurysm that are considered candidates for endovascular repair, per the FDA approved IFU.

Device: Talent Abdominal Stent Graft

Interventions

The Talent Abdominal Stent Graft is indicated for the endovascular treatment of abdominal aortic aneurysms with or without iliac involvement.

Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject must have an abdominal aortic aneurysm, with or without iliac involvement.
  • Iliac/femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;
  • A proximal aortic neck length of ≥ 10mm;
  • Proximal aortic neck angulation ≤ 60°;
  • Distal iliac artery fixation length of ≥ 15mm;
  • An aortic neck diameter of 18-32mm and iliac artery diameters of 8-22mm; and
  • Vessel morphology suitable for endovascular repair.

You may not qualify if:

  • Are less than 18 years of age
  • Are pregnant or lactating
  • Have a dominant patent inferior mesenteric artery and an occluded or stenotic celiac and/or superior mesenteric artery
  • Have aneurysmal involvement or occlusion (surgically performed or naturally occurring) of the bilateral internal iliac arteries
  • Have vessels and/or aneurysm dimensions that cannot accommodate the Talent Abdominal Stent Graft as per the indications in Section 3.
  • Have no distal vascular bed (one vessel lower extremity run-off required)
  • Have contraindications for use of contrast medium or anticoagulation drugs
  • Have an uncorrectable coagulopathy
  • Have an SVS/AAVS score greater than 2
  • Have a mycotic aneurysm
  • Have circumferential mural thrombus in the proximal aortic neck
  • Have had a recent (within 3 months) myocardial infarction (MI), cerebral vascular accident (CVA), or major surgical intervention
  • Have traumatic aortic injury
  • Have leaking, pending rupture or ruptured aneurysms
  • Have pseudoaneurysms resulting from previous graft placement
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (18)

USC Univerisity Hospital

Los Angeles, California, 90033, United States

Location

Palo Alto VAMC

Palo Alto, California, 94304, United States

Location

Christiana Care Health Services

Newark, Delaware, 19713, United States

Location

Washington Hospital Center

Washington D.C., District of Columbia, 20010, United States

Location

Mayo Clinic Jacksonville

Jacksonville, Florida, 32224, United States

Location

St. John's Medical Research Institute

Springfield, Missouri, 65810, United States

Location

Barnes Jewish

St Louis, Missouri, 63110, United States

Location

East Carolina University

Greenville, North Carolina, 27834, United States

Location

Forsyth Medical Center

Winston-Salem, North Carolina, 27103, United States

Location

Lehigh Valley Hospital

Allentown, Pennsylvania, 18103, United States

Location

Pinnacle Health Network

Harrisburg, Pennsylvania, 17110, United States

Location

Sanford USD Medical Center

Sioux Falls, South Dakota, 57104, United States

Location

North Central Heart Institute

Sioux Falls, South Dakota, 57108, United States

Location

St. Mary's Medical Center

Knoxville, Tennessee, 37923, United States

Location

Vanderbilt Vascular Surgery

Nashville, Tennessee, 37232, United States

Location

Wilford Hall Medical Center

Lackland Air Force Base, Texas, 78236, United States

Location

Inova Fairfax Hospital

Falls Church, Virginia, 22042, United States

Location

Charleston Area Medical Center

Charleston, West Virginia, 23504, United States

Location

MeSH Terms

Conditions

Aortic Aneurysm, AbdominalAortic AneurysmAneurysm

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesAortic Diseases

Results Point of Contact

Title
Rianna Rapson
Organization
Medtronic

Study Officials

  • Luis Sanchez, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2008

First Posted

December 31, 2008

Study Start

December 1, 2008

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

October 29, 2021

Results First Posted

January 23, 2018

Record last verified: 2021-10

Locations